Geron (GERN) Gains from Investment Securities (2010 - 2024)

Geron's (GERN) quarterly Gains from Investment Securities came in at $40.8 million in Q4 2024, down 44.1% year-on-year from $73.0 million in Q1 2024, and up 13500.0% quarter-over-quarter from $300000.0 in Q3 2024.

Geron (GERN) Gains from Investment Securities (2010 - 2024) Analysis & Trends

Geron has disclosed Gains from Investment Securities across 14 years of filings, most recently posting $40.8 million for Q4 2024.

  • Gains from Investment Securities for Q4 2024 came in at $40.8 million, down 44.1% year-over-year; the trailing twelve-month figure through Dec 2024 was $41.2 million (down 43.55% YoY), and the FY2024 annual result was $76.0 million, up 4.09% from the prior year.
  • Gains from Investment Securities came in at $40.8 million for Q4 2024 at Geron, up from $300000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $73.0 million in Q4 2023 to a low of -$499000.0 in Q2 2020.
  • The 5-year median for Gains from Investment Securities is $363500.0 (2020), against an average of $11.8 million.
  • Across the five-year window, Gains from Investment Securities sank 570.75% in 2020 and jumped 2561.96% in 2023, its largest moves.
  • Geron's Gains from Investment Securities stood at -$131000.0 in 2020, then surged by 1041.22% to $1.2 million in 2021, then jumped by 122.36% to $2.7 million in 2022, then surged by 2561.96% to $73.0 million in 2023, then plunged by 44.1% to $40.8 million in 2024.
  • The last three Gains from Investment Securities figures came in at $40.8 million (Q4 2024), $300000.0 (Q3 2024), and $100000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Geron 729,618.77 729,618.77 -

Historic Data

Download Data
DateValue
Dec 31, 2024 40.80 Mn
Dec 31, 2024 40.80 Mn
Sep 30, 2024 300,000.00
Sep 30, 2024 300,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Dec 31, 2023 72.98 Mn
Dec 31, 2023 72.98 Mn
Dec 31, 2022 2.74 Mn
Dec 31, 2022 2.74 Mn
Mar 31, 2021 1.23 Mn
Mar 31, 2021 1.23 Mn
Dec 31, 2020 -131,000.00
Dec 31, 2020 -131,000.00
Sep 30, 2020 427,000.00
Sep 30, 2020 427,000.00
Jun 30, 2020 -499,000.00
Jun 30, 2020 -499,000.00
Mar 31, 2020 220,000.00
Mar 31, 2020 220,000.00